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A B S T R A C T
This study aimed to show the difference of epilepsy from another chronic neurological disorder with
episodic manifestations (CDEM): migraine. Seventy persons with epilepsy (PWE), 56 persons with
migraine (PWM) and 45 healthy control participants (HCs) were included. The groups were compared in
terms of demographics, quality of life, depression and self-esteem. The PWE and PWM were also
compared with regard to stigma, impact of the illness, disclosure, application of spiritual/traditional
healing methods, limitations, most affected life areas, and restrictions. Results showed that the PWM had
lower quality of life values than the PWE and the HCs, while there was no difference among the groups in
depression and self-esteem. Results also show higher unemployment levels and lower marriage rates for
the PWE, where education levels were equal. Although the PWM had higher impact of illness values, the
PWE were shown to have higher stigma, more concealment behavior, and higher traditional/spiritual
healing application ratios. Also, the PWM emphasized the importance of being ‘‘able to fulﬁl daily living,
social and work activities’’, while the PWE emphasized the need for ‘‘independence’’ constantly. These
results indicate that, although both migraine and epilepsy are CDEMs, they have different levels of
impact on patients’ lives. The impacts are socially greater in epilepsy and extend beyond the neurological
condition itself.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epilepsy is a common chronic neurological disorder which is
characterized by recurrent seizures. However, classifying epilepsy
merely as a neurological disorder is inadequate since it is also a
disorder with negative social consequences. Persons with epilepsy
(PWE) usually suffer from unemployment and/or underemploy-
ment, lower marriage rates, and social discrimination.1–4 All these
factors usually result in an impaired quality of life and low self-
esteem, which is intensiﬁed by the seizures themselves,5,6 and
sometimes even by antiepileptic drug (AED) use.7–9 For most PWE,
a diagnosis of epilepsy is equal to stigmatization,10,11 in particular
felt stigma,12 which in turn results in concealing epilepsy from
others and spending a great amount of energy on this conceal-
ment.13–15 This situation also creates a serious psychological
burden and sometimes social restrictions in their lives. Addition-
ally, many PWE suffer from depression, which also impairs quality
of life and introduces additional problems.6,16–18Moreover, a range* Corresponding author. Tel.: +90 232 488 85 25; fax: +90 232 279 26 26.
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doi:10.1016/j.seizure.2011.06.017of mythological and superstitious beliefs seem to surround
epilepsy in every culture,19,20 creating a body of unscientiﬁc and
misguided attitudes. This in turn, leads to the practice of traditional
and spiritual healing methods, which can be observed across a
wide spectrum of cultures.13,21–23
Migraine is another very common neurological disorder which
is characterized by recurrent attacks of pain and associated
symptoms.24 Both epilepsy and migraine are neurological chronic
disorders with episodic manifestations (CDEMs).25 Although the
duration of the symptoms varies greatly in these two disorders,
individuals with either condition may have symptom free periods
between attacks/seizures. In both illnesses, neurological attacks
can be accompanied by headache as well as by variant
gastrointestinal, autonomic and psychological features.26 It is
believed that both result from brain hyperexcitability.27 Both are
umbrella disorders, each of which constitutes a heterogeneous
family of disorders. In some cases, common drugs – such as,
valproic acid and topiramate – are used in the treatment of
both.28,29 Additionally, like epilepsy, migraine can cause impaired
quality of life,30–33 and generally has a negative impact on life.34
Mood disorders, especially anxiety and depression, are also
common comorbid conditions in migraine and epilepsy.30,35vier Ltd. All rights reserved.
Table 1
Demographic characteristics of epilepsy, migraine and control groups.
Groups Epilepsy
(n = 70)
Migraine
(n = 56)
Healthy control
(n = 46)
Sex (%)*
Female 68.6 87.5 60.9
Age (SD)* 32.3 (10.5) 40.5 (10.4) 35.7 (11)
Year of education (SD) 9.2 (3.9) 9.0 (4.4) 9.3 (4.4)
Marital status (%)*
Single 48.6 12.5 15.2
Married 42.9 82.1 73.9
Divorced 2.9 – 6.5
Widow 5.7 5.4 4.3
Occupational status (%)*
Employed 47.1 33.9 71.7
Unemployed 14.3 5.4 2.2
Housewife 22.9 41.1 19.6
Student 14.3 5.4 4.3
Retired 1.4 4.3 2.2
* p < 0.00.
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tute different disorders. There are a number of previous studies in
which epilepsy is compared with other chronic illnesses, such as
angina pectoris, rheumatoid arthritis, asthma, chronic obstructive
pulmonary disease, migraine, atopic dermatitis, cerebral palsy, and
cystic ﬁbrosis.36–39 However, the aim of using migraine as a second
research group is to highlight the contrasts between epilepsy and
another illness with very similar features. The reason for this is that
observed differences in quality of life between PWE and people with
other chronic illnesses with very different symptoms could be
attributed to the completely different etiologies and symptoms of
the disorders. By using migraine therefore, it is aimed to examine
possible differences between epilepsy and a similar illness in order
to eliminate confounding nature of the symptoms and etiologies.
Hence, any difference observed could be directly attributed to the
speciﬁc nature of epilepsy.
Therefore, the present study aimed to compare PWE and
persons with migraine (PWM) in terms of health related quality of
life, self-esteem, impact of illness, depression, stigma and
disclosure. Other affected life domains and application of
spiritual/traditional healing methods were also investigated in
order to understand more about what makes epilepsy different.
Based on previous studies, we expected: (1) lower health related
quality of life (HRQOL) values in PWM and PWE than Control
participants (CPs), and in particular that PWM would have lower
HRQOL values on the subscales related with physical health, and
PWE have lower values on the subscales related with mental
health; (2) higher depression and stigma rates and lower self-
esteem values in PWE; (3) higher impact of illness scores in PWM;
(4) more application of traditional/spiritual healing methods in
PWE; and (5) more concealment of the illness in PWE.
2. Methods
2.1. Participants
The epilepsy group consisted of seventy participants diagnosed
with epilepsy at least for four years previously, and who
experienced at least one seizure within the last two years and/
or who are still on AEDs. All participants in the epilepsy group had
detailed neurological and neuropsychological evaluations, and
patients with below average IQs (less than 90) were not included in
the study. Patients with additional serious impairments (e.g.
hearing, seeing, etc.) and those with other neurological and
psychiatric disorders were also excluded.
For the migraine group, 56 adults with migraine were recruited.
The selection criteria were experiencing migraine attacks for an
absolute minimum of four years, including at least one attack in the
last three months, and continuing treatment at a headache
polyclinic and as well as being on prescribed medication. Likewise,
PWM with below average IQs (less than 90), with additional
serious impairments, and those with other neurological and
psychiatric disorders were also excluded. Since epilepsy and
migraine are highly comorbid, patients who have migraine or
epilepsy as a comorbid condition were excluded from the study. All
the participants with migraine and epilepsy were recruited during
their follow-up appointments in the neurology clinic.
A control group, consisting 45 healthy adults with no history of
neurological and psychiatric disorders was included. The control
participants (CPs) were matched with the epilepsy and migraine
groups in terms of age, gender, and year of education as far as
possible (see Table 1).
The present study was approved by the Cerrahpas¸ a School of
Medicine, and Faculty of Ethics Committee [31.01.2006, No: 2378]
at Istanbul University. Additionally, all the participants gave
inform consent for their participation in the study.2.2. Instruments
2.2.1. Health related quality of life (HRQOL)
We used the Medical Outcomes study short form-36 (SF-36),40
which consists of eight subscales to evaluate different domains of
HRQOL: (1) physical functioning (PF); (2) role limitations because
of physical health problems (RP); (3) bodily pain (BP); (4) social
functioning (SF); (5) general mental health (psychological distress
and psychological well being) (MH); (6) role limitations because of
emotional problems (RE); (7) vitality (energy/fatigue) (VT); and (8)
general health perception (GH). The total score varies between 0
and 100, with higher scores representing a better quality of life.
Although it is a generic measure, SF-36 has been used in previous
quality of life research in epilepsy.7,39,41–50 The validity and
reliability of SF-36 for Turkish population have been tested by
Demirsoy.51
2.2.2. Depression
The Beck Depression Inventory (BDI),52 a 21 item scale, was
administered to assess the depression levels of the participants.
The total score varies between 0 and 63, with higher scores
indicating the severity of the depressive symptoms. In the present
study, 17 was accepted as a cut off point for severe depression. The
validity and reliability of the BDI for the Turkish population have
been tested by Hisli.53
2.2.3. Stigma
A three item scale developed by Jacoby54 was used. In this scale,
subjects are asked to state whether, because of their epilepsy, they
felt that other people are (1) uncomfortable with them, (2) treated
them as inferior, and (3) preferred to avoid them. The subjects
marked each item with which they agreed. The subject’s overall
score (0–30) is the sum of positive responses, therefore the higher
the score, the greater sense of stigma. The reliability of the scale
was found to be 0.72.54
2.2.4. Impact of illness
The Perceived Impact of Epilepsy Scale, developed by Jacoby
et al.55 was administered to determine the impact of epilepsy on
daily life. The scale contains both generic and epilepsy-speciﬁc
items. All items cover the most important areas of everyday life,
including relationships with spouse/partners, relationships with
other close family members, social life/social activities, work,
health, relationships with friends, feelings about self, and plans and
ambitions for the future. When the scale was administered to
patients with migraine, the term ‘‘migraine’’ replaced ‘‘epilepsy’’ in
Table 2
Clinical characteristics of the epilepsy and migraine groups.
Epilepsy group
(n = 70)
Migraine group
(n = 56)
Duration of the illness (SD) 16.6 (10.6) 15.8 (10.1)
Duration of the diagnosis* (SD) 14.9 (11.9) 10.0 (8.3)
Number of medication** (SD) 1.6 (0.8) 2.0 (0.9)
Seizure/attack frequency
(per month) (%)
None: 12.9 None: 0
ten: 72.9 three: 37.5
ten: 13.3 three: 62.5
Comorbidity (%)*
Yes 11.4 42.9
Seizure type (%)
Generalized tonic-clonic 45.7
Simple partial 18.8 –
Complex partial 21.4
Absence 2.9
Myoclony 11.4
Intractable seizures (%)
Yes 58.6 –
* p < 0.05.
** p < 0.02.
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the ailment.
2.2.5. Self-esteem
In order to assess the self-esteem of the participants, the
Coopersmith Self-Esteem Inventory (CSEI)-Adult version was
used.56 Participants were asked to evaluate every item either as
‘‘like me’’ or ‘‘not like me’’. The scale consists of 25 items. The
validity and reliability of the scale for the Turkish population were
tested by Turan and Tufan.57
2.2.6. Clinical/demographic questionnaire
In order to collect information about the participants’ clinical
and demographic characteristics different questionnaires were
developed for different groups. The questionnaire for the epilepsy
and migraine groups contained questions about seizure/attack
frequencies, the amount of medication used, the duration of the
illness, the duration of the diagnosis, and the existence of other
chronic conditions. Moreover, participants were asked whether
they had ever concealed their illnesses, and if so the duration of and
reasons for the concealment. Additionally, participants with
epilepsy and migraine were asked about any spiritual healing
methods they may have tried, and their opinion of the effective-
ness of these methods. Lastly, participants with epilepsy and
migraine were asked to report their concerns, limitations and most
affected life domains in their own words in order to determine the
issues of critical importance, which could not be otherwise
detected by scales with predetermined frameworks. Another
reason was to provide an opportunity for participants to explain
what it is like to live with these disorders. The CPs’ questionnaire
sought information only on demographic issues and any chronic
health conditions.
Participants completed the information form ﬁrst, and then the
epilepsy and migraine groups received the SF-36, BDI, stigma
inventory, impact of epilepsy/migraine inventory and CSEI in a
randomized order, in order to avoid the order effect. The CPs did
not receive the stigma and the impact of epilepsy/migraine
inventories, but all other scales were administered in a randomized
order. All administrations were carried out in face to face
interviews by the ﬁrst author.
2.3. Statistical analysis
The data were analyzed using SPSS for Windows, version 17. For
two grouping variables, t tests for independent samples were used,
while data for more than two grouping variables were analyzed by
means of One-Way ANOVA. For categorical variables, Chi-Square
was performed.
For the qualitative analysis of the open-ended questions ﬁrst, all
of the answers were transferred to Excel verbatim. Following this,
open-ended answers were examined by two coders who applied
content analysis to the raw data. They determined some common
themes and categories then classiﬁed all answers accordingly,
resolving any differences regarding the classiﬁcation between
themselves. Both coders had master’s degrees in psychology, and
were blind to the aims of the study, but not to the diagnosis of the
participants.
3. Results
3.1. Demographic and clinical characteristics
No signiﬁcant differences were found among the epilepsy,
migraine and control groups in terms of year of education (F < 1).
On the other hand, age (F (2, 169) = 9.21, p < 0.00), gender (X2 (2,
N = 172) = 0.291, p = 0.01), marital status (X2 (6, N = 167) = 11.09,p = 0.00) and occupational status (X2 (8, N = 172) = 2.12, p = 0.00)
were found to be signiﬁcantly different among the groups (see
Table 1).
Results showed that there was no signiﬁcant difference between
the epilepsy and migraine groups in terms of their duration of the
illness, while there were signiﬁcant differences between how long
they had known their diagnosis (t = 2.75, df = 124, p < 0.00) and the
amount of medication currently used (t = 2.63, df = 124, p < 0.02).
There was also a signiﬁcant difference between the epilepsy and
migraine groups in terms of having a comorbidity (X2 (1,
126) = 16.56, p = 0.00). The results indicated that the PWE had
known their diagnosis longer, but that the PWM used a greater
amount of medication and were more likely to have a comorbidity.
Additionally, the time gap between the onset of the seizures/attacks
and receiving the diagnosis was only M = 1.73(3.63) years for
epilepsy, but M = 5.84(6.7) years for migraine (see Table 2).
3.2. Health related quality of life, depression and self-esteem
Results showed that, except for role limitations because of
emotional problems (F < 1) and general mental health (F < 1),
signiﬁcant differences were observed in all the other sub-scales of
the SF-36 [physical functioning (F (2, 169) = 11.84, p < 0.00), role
limitations because of physical health problems (F (2, 169) = 12.72,
p < 0.00), bodily pain (F (2, 169) = 21.54, p < 0.00), social
functioning (F (2, 169) = 4.79, p < 0.01), vitality (F (2, 169) = 8.1,
p < 0.00) and general health perception (F (2, 169) = 7.94,
p < 0.00)]. Tukey post hoc analysis revealed that, in physical
functioning, role limitations because of physical health problems,
bodily pain, social functioning, and vitality subscales, the migraine
group was at a signiﬁcant disadvantage compared to the epilepsy
and control groups. Only in general health perception, CPs had
higher scores than epilepsy and migraine groups (see Fig. 1).
The results showed that neither depression (F < 1) nor self-
esteem (F < 1) were signiﬁcantly different among the groups.
When the results were investigated in terms of percentages, 30% of
the PWE and 25.2% of the PWM were in serious depression,
compared to only 15.1% for the CPs.
3.3. Stigma, impact of epilepsy/migraine, and disclosure of the illness
Results indicated signiﬁcant differences for both stigma (t = 2.75,
df = 124, p = 0.01) and impact (t = 4.15, df = 124, p = 0.00) of
epilepsy/migraine, such that the PWE reported signiﬁcantly higher
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Fig. 1. Mean values of the groups in sub-scales of the quality of life, depression and self-esteem.
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Serious stigma was observed only in 14.2% of the PWE, while this
ratio was only 3.6% in PWM.
There was also a signiﬁcant difference in disclosure (X2 (1,
N = 125) = 29.67, p = 0.00) rates between the epilepsy and migraine
groups. Results showed that none of the migraine participants
concealed their condition from others, whereas regarding disclo-
sure, 41% of the PWE had at one point concealed their epilepsy: 31%
concealed it within the ﬁrst few years following the diagnosis,
while 69% still conceal it.
3.4. Reasons for concealment of epilepsy
In order to evaluate the reasons for the concealment of epilepsy,
the responses were investigated by the two independent coders
mentioned earlier. Any response citing an inner fear of stigmatiza-
tion without an actual discriminatory episode was coded as ‘‘felt
stigma’’; but if there was real experienced discrimination caused by
epilepsy, it was coded as ‘‘enacted stigma’’.12 A frequency analysis
showed that 89.7% of the PWE stated felt stigma as a reason for their
concealment. ‘‘I want people to evaluate me as if nothing is wrong
with me, I am as healthy as they are’’ [F, 35], ‘‘I do not want to divulge
it, I do not want to be treated as inferior’’ [M, 21]. Only 10.3% of the
PWE concealed their epilepsy because of enacted stigma: ‘‘After
people learned about my epilepsy, they acted with prejudice, so I
told just my boss and close friend, no one else’’ [F, 28].
3.5. Application of spiritual healing methods
Among the participants with epilepsy, 55.7% had applied any
spiritual healing methods, in contrast to only 12.2% of the migraine
participants. The most common applications were lead casting
(melting lead and pouring it into cold water over the head of a sick
person in order to break an evil spell), carrying a written charm,
and consulting a Hodja. The results showed that (X2 (1,
N = 125) = 24.47, p = 0.00) the PWE applied spiritual healing
methods to a signiﬁcantly greater extent than the PWM. However,
92% of the PWE evaluated spiritual methods as not beneﬁcial, as
did 95.2% of the migraine group. There was no difference between
the PWE and the PWM in their evaluation of spiritual healing
methods as non-beneﬁcial.
3.6. Most reported concerns, affected life domains, and restrictions
For the PWE the most frequently reported concern was ‘‘having
a seizure outdoors’’, while for the PWM it was ‘‘being unable tofulﬁl daily living activities’’ and ‘‘the possibility of having a
migraine attack’’. Other reported concerns by the PWE, according
to their report frequencies, were ‘‘being alone while having a
seizure’’, ‘‘having an accident or dying due to a seizure’’, ‘‘having a
child’’, ‘‘ambiguity about the future’’, ‘‘AEDs’’, ‘‘being a burden to
others’’, ‘‘negative consequences on independence’’, ‘‘deterioration
in mental health’’ and ‘‘relations with the opposite sex’’. The other
concerns reported by the PWM were ‘‘long term damage to health
caused by migraine’’, ‘‘deterioration in mental health’’, ‘‘relations
with the opposite sex and family’’, ‘‘ambiguity about the future’’,
and ‘‘low performance at work’’.
The most frequent responses to the question about which were
the most affected life domains due to epilepsy were: ‘‘work/
education/family life’’, ‘‘personal independence’’, ‘‘social-physical
activities’’, ‘‘cognitive abilities’’, ‘‘psychological well being’’,
‘‘romantic relations’’, ‘‘physical health’’ and ‘‘driving’’. The answers
given by the PWM to the same question were; ‘‘social life/daily
living activities’’, ‘‘relations with the opposite sex and with family’’,
‘‘psychological well being’’, ‘‘work/family life’’, ‘‘cognitive abili-
ties’’, and ‘‘physical health’’.
To the question about the restrictions caused by epilepsy, the
responses given by the PWE, in decreasing order of frequencies
were: ‘‘driving’’, ‘‘social-physical activities’’, ‘‘lack of indepen-
dence’’, ‘‘avoiding activities which can trigger a seizure’’, ‘‘educa-
tion/work life’’ and ‘‘compulsory military service’’. The responses
of the PWM to the same question were: ‘‘avoiding activities which
can trigger a migraine attack’’, ‘‘social-physical activities’’, and
‘‘daily living activities’’.
4. Discussion
4.1. Differences in demographics and clinical characteristics
The results showed no difference among the groups in their
level of education, as reported by previous studies.1,4,58 However,
the PWE were more likely to be unmarried and unemployed when
compared with the PWM and the CPs, a ﬁnding consistent with
previous reports.1,4,59 The point to emphasize here is that the lower
marriage and higher unemployment rates in the PWE were not
related to the level of education, which was approximately equal
across the groups. Therefore, this suggests that other possible
reasons, such as felt and/or enacted stigma may be responsible.60
When the epilepsy and migraine groups were compared in
terms of their clinical characteristics, it was found that the epilepsy
group had been aware of their diagnosis for longer than the
migraine group. This difference is probably caused by the feeling of
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other hand, the PWM used more medication and had more
comorbid conditions than the PWE.
4.2. Quality of life, depression and self-esteem
In terms of the quality of life results, contrary to expectations,
the PWE only scored lower than the CPs on the general health
perception subscale of the SF-36, while on the other subscales the
scores of the two groups were comparable. As expected, and
consistent with previous studies,31,32,61,62 the PWM received lower
scores in physical functioning, role limitations because of physical
health problems, bodily pain, social functioning and vitality
subscales than the epilepsy and the CPs, showing a lower quality
of life among the PWM. This ﬁnding is also in contrast to studies
which showed that PWE have lower quality of life scores when
compared to general reference population,7,41,48,49 and to a recent
study,36 that compared epilepsy, migraine and diabetes, ﬁnding
that PWE are more likely than PWM to rate their health as only
‘‘fair’’ and ‘‘poor’’. A small number of studies have shown that if the
seizures are under control, PWE have similar quality of life values
to general population.63–65 In the present study however, more
than half of the participants had intractable seizures. The
comparable scores in HRQOL scores between the epilepsy group
and the CPs in the present study are reﬂected in previous studies.
For example, in a study by Stavem et al.39 PWE were compared
with participants with other diseases, and were found to have
higher quality of life values. The researchers suggest that PWE have
better overall health perception than people with many other
chronic illnesses.39 As in the present study’s ﬁnding, Aldenkamp
et al.58 found that only 6% of participants with epilepsy had lower
quality of life values. Additionally, previous studies from other
Muslim and collectivistic countries such as Tunisia,43 Jordan,66
Bahrain, Lebanon and Qatar41 support the present study’s ﬁndings.
This could be explained by the effect of Islamic religion which
emphasizes acceptance of God’s will in every condition, and tends
to regard attitudes which are hostile to the idea of destiny as a
major act of sinfulness. Also, as stated by Kag˘ıtc¸ıbas¸ ı,67 the concept
of culture of relatedness (collectivism) prominent in the afore-
mentioned countries, refers to contexts and relational patterns
characterized by relations between connected, expanding and
therefore, partially overlapping selves, which have diffuse
boundaries (p110).67 Therefore, in these societies with closely
knit human/family relations, the family unit could serve as a buffer
to soften the negative impacts of a chronic illness, which include
impacts on the patient’s quality of life. In order to clarify our
understanding of the HRQOL in both Muslim and collectivistic
countries, more research is needed. Another explanation, sug-
gested by Selai et al.68may be that rather than considering epilepsy
as part of their general well being, PWE treat it as a separate entity.
A ﬁnal explanation could be the generic structure of the SF-36.
Since the SF-36 contains items which speciﬁcally aim to assess
pain and the limitations it causes, it may be more sensitive to
illnesses like migraine.
Contrary to our expectations, the present results for depression
show no difference among the PWE, the PWM and the CPs.
Although more than half of the participants had intractable
epilepsy, only one-third of the participants with epilepsy were
found to be depressed, consistent with previous studies.18,46,64,69,70
Regarding self-esteem, again contrary to expectations, the PWE
were no different from the PWM and the CPs. This ﬁnding is also in
accordance with previous reports.15,71 On the other hand, there are
studies that indicate that self-esteem is negatively affected by
epilepsy-related variables, such as the existence of intractable
seizures, side effects and the amount of AEDs.72 The contradictory
results from different studies so far indicate that further research isneeded in particular to understand the effects of intractable
seizures.
4.3. Impact of illness, stigma, and disclosure
In accordance with our expectations, the impact of migraine
was found to be higher than the impact of epilepsy. Although the
PWM were shown to have lower quality of life and higher impact of
illness scores and there was no difference between the epilepsy
and migraine groups in depression and self-esteem, stigma is more
prominent in the PWE, as we expected. Therefore, stigma seems
uniquely associated with epilepsy, independent of the neurological
symptoms and psychological well-being. The percentage of the
PWE with a high level of stigma in the present study is also
consistent with previous results.42,54,73,74 Another interesting
ﬁnding, also in line with our expectations, was that almost half
the PWE have concealed/or still conceal their illness, whereas none
of the PWM ever did. This result alone shows that epilepsy is a
disorder with considerable negative social connotations. In the
present study, among those who concealed their epilepsy at some
point, only about a quarter stopped concealment within few years
of following diagnosis, while most still continue to do so. Hence,
rather than being just a reaction to the initial astonishment, shock
and ambiguity of the diagnosis, concealment seems to relate to
more serious, long term concerns and almost all the PWE stated felt
stigma as a reason.
4.4. Application of spiritual treatments
A ﬁnal ﬁnding which shows the unique nature of epilepsy as
being more than simply a neurological disorder was the clearer
tendency of the PWE compared to the PWM to resort to spiritual
healing methods as expected. Despite this tendency, most
participants evaluated these methods as non-beneﬁcial. In a
similar study, Small et al.75 found that Pakistani Muslims with
epilepsy living in England simultaneously seek help from
physicians and from religious healers. In explanation, the
researchers point to the hybrid culture that the participants were
exposed to, and to the neurological and spiritual components to
which epilepsy is attributed to. This explanation is also likely to be
valid for Turkish individuals with epilepsy because of the inﬂuence
of both Eastern and Western values.
4.5. Most reported concerns, limitations and affected life domains
In the present study the PWE and the PWM were asked to report
their concerns, limitations and most affected life domains in their
own words to determine critically important issues in their lives. A
categorization of the answers indicated that the most reported
concern for the PWE was ‘‘having a seizure outdoors’’ followed by
‘‘being alone during a seizure’’, which are in accordance with
previous ﬁndings.76–78 As previously highlighted,76,78,79 fear of
seizure, and of seizure-related death can cause an impaired
psycho-social adaptation to epilepsy, the higher the degree of these
fears, the greater the psychopathological risk. These concerns
should be treated with sufﬁcient consideration to reduce the
impact of such limitations on the lives of PWE in general. The most
important concern reported by the PWM was ‘‘not fulﬁlling their
daily/social activities’’ which is an expected concern since during
the migraine attack most of the PWM were unable to perform daily
domestic and work related activities.
As their most affected life domain, the PWE reported ‘‘Work/
education/family life’’. The most affected life domain reported by
the PWM was ‘‘social life/daily living activities’’. Lastly, both the
epilepsy and migraine groups were asked to report the limitations
caused by their illnesses. ‘‘Driving’’ was the most reported concern
N. Aydemir et al. / Seizure 20 (2011) 679–685684by Turkish adults with epilepsy, in common with their Western
counterparts.80–82 The most reported category by the PWM was
‘‘avoiding behaviours which can trigger a migraine attack’’.
When the answers given by the PWE to the three open-ended
questions were investigated, only ‘‘independence’’ emerged as a
common category. The main reason for this is likely to be the
overprotective behaviours of families toward individuals with
epilepsy, starting immediately after diagnosis, which can damage
the self-esteem and independence of patients.5 Especially in a
country like Turkey with very strong family ties, this situation
tends to result in a family-dependent patient. For this reason, most
of the PWE were unable to travel alone or access higher education,
and were therefore likely to be unemployed.
4.6. Limitations of the study
The most important limitation of the present study is the
demographic differences among the three study groups, especially
between the epilepsy and migraine groups in terms of their attack/
seizure frequencies. Another limitation is the selection of
participants from a hospital rather than the general population,
since some ﬁndings indicate that, especially for migraine, such
patients are more likely to have severe migraine, more frequent
attacks and more comorbid illnesses (Clouse and Osterhaus, 1994,
cited in Ref. 31]. Additionally, patients under the care of a
neurologist in a hospital setting may be different from those
without this opportunity in terms of their seizure/attack control
and adjustment to their illness. Therefore, the epilepsy and
migraine patients in this study may not be representative the
general migraine and epilepsy population.
5. Conclusion
In contrast to many previous studies, the present study showed
that the participants with a high number of intractable seizures
had quality of life, psychological well being, and self-esteem values
not dissimilar to those of the CPs. On the other hand, almost half of
the PWE had concealed/still conceal their epilepsy. Additionally,
the higher unemployment and lower marriage rates, and impaired
personal independence indicate that PWE still struggle, especially
with social problems. Furthermore, comparisons with the PWM
indicate that the probable causes of these problems extend beyond
the neurological condition itself.
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